| Effective Term: | 2024/05 |
| Institute / School : | Institute of Health and Wellbeing |
| Unit Title: | Pharmacology for Advanced Practice |
| Unit ID: | HEANP6002 |
| Credit Points: | 15.00 |
| Prerequisite(s): | (HEANP6001 and HEANP6003) |
| Co-requisite(s): | Nil |
| Exclusion(s): | Nil |
| ASCED: | 060399 |
| Other Change: | |
| Brief description of the Unit |
This course develops the necessary knowledge and skills required of independent prescribers. Principles of pharmacodynamics and pharmacokinetics, together with knowledge of indications, side effects of treatments and risk management strategies will be explored. Critical thinking decisions on therapeutic management (pharmacological and non-pharmacological) options, collaboration with other health care providers and evaluation strategies will be explored. The use of digital technologies to support prescribing practices will be explored. Students will maintain a clinical log during their 50 hours of interprofessional practice which will incorporate reflections of their learning. |
| Grade Scheme: | Graded (HD, D, C, P, MF, F, XF) |
| Work Experience Indicator: |
| No work experience |
| Placement Component: | Yes - 7 days |
| Supplementary Assessment:Yes |
| Where supplementary assessment is available a student must have failed overall in the Unit but gained a final mark of 45 per cent or above, has completed all major assessment tasks (including all sub-components where a task has multiple parts) as specified in the Unit Description and is not eligible for any other form of supplementary assessment |
| Course Level: |
| Level of Unit in Course | AQF Level(s) of Course | | 5 | 6 | 7 | 8 | 9 | 10 | | Introductory | | | | | | | | Intermediate | | | | | | | | Advanced | | | | |  | |
|
| Learning Outcomes: |
| Knowledge: |
| K1. | Evaluate the principles of pharmacodynamics and pharmacokinetics in relation to human biology |
|
| K2. | Appraise the indications, actions, adverse effects and contraindications for commonly prescribed medications |
|
| Skills: |
| S1. | Develop relevant communication skills to inform individuals about therapeutic interventions |
|
| S2. | Engage in partnerships with individuals to plan and implement management plans |
|
| Application of knowledge and skills: |
| A1. | Critically evaluate knowledge of and commitment to therapeutic relationships to achieve optimal person centred outcomes |
|
| A2. | Demonstrate pharmacological knowledge to inform actions related to the commencement/alteration/ceasing of interventions to achieve best healthcare outcomes |
|
| Unit Content: |
The ANMAC Nurse Practitioner Accreditation Standards (2015); The NMBA Nurse Practitioner Standards for Practice (2021); NMBA Code of Conduct for Nurses (2018) and Code of Ethics for Nurses (2018), Safety and Quality Guidelines for Nurse Practitioner (2021); National Safety and Quality Health Service (NSQHS) Standards (2017-19); Aged Care Quality Standards (2021), National Digital Health Framework (2021; Aboriginal and Torres Strait Islander Health Curriculum Framework (2020) and National Prescribing Competencies Framework (2021) have substantially informed the syllabus/content of this course.
Pharmacodynamics and pharmacokinetics
Therapeutic interventions
Pharmacological characteristics of drug classes
Pharmacological and non-pharmacological interventions
National Prescribing Competencies Framework (2021) contextualised |
| Graduate Attributes: |
| | Learning Outcomes Assessed | Assessment Tasks | Assessment Type | Weighting | | 1. | K1, K2, A2 | Theoretical concepts and skills application of advanced practice to a clinical scenario. | Case Study | 40-50% | | 2. | K1, K2, A1, A2 | Examination of theoretical concepts and skills application covered in course content and extended learning activities. | End of semester test | 50-60% | | 3. | K1, K2, S1, S2, A1, A2 | Clinical inter professional practice (clinical supervision team) 50 hours | Clinical Practice Assessment tool | S/U |
|